A new imaging technique combines ultrasound and specially modified contrast agents to detect cancer at the molecular level, allowing for early detection and potentially saving lives. The technique uses microbubbles paired with a peptide that binds to tumor vessel cells, enabling visualization of tumor activity.
A new study provides clear pediatric PET dose guidelines, allowing clinicians to calculate the optimal radiotracer dose based on a child's weight. The findings suggest that patients can receive high-quality images with reduced scan time or lower doses, minimizing radiation exposure for young children.
The Society of Nuclear Medicine and Molecular Imaging's Clinical Trials Network Workshop explored the integration of imaging biomarkers into clinical trials, emphasizing quality and standardization. Experts shared insights on overcoming challenges and harmonizing data across multiple sites.
The summit explored ways to use nanotechnology in medical imaging and therapy, focusing on targeting diseases such as cancer, neurological conditions, and cardiovascular disease. Experts discussed regulatory frameworks, design considerations, and future directions for this rapidly evolving field.
A large-scale study demonstrates that transplanted cells produced dopamine, leading to improved motor symptoms and brain function. Long-term clinical outcomes revealed sustained improvements over a four-year period.
Researchers found that a combination of single photon emission computed tomography (SPECT) and low-dose CT provided accurate diagnoses with high sensitivity and specificity. The study suggests that this technique may improve patient outcomes by reducing the mortality rate associated with untreated pulmonary embolism.
Researchers used PET scans to identify neuroinflammation in the brains of schizophrenics and migraine sufferers, shedding light on the underlying causes of these conditions. The findings have the potential to transform diagnosis and treatment options, particularly for schizophrenia.
A new molecular imaging technique using PET imaging shows promising results in evaluating and predicting the course of endometrial carcinoma. The technique combines estrogen receptor expression imaging with 18F-FDG PET to improve diagnostic accuracy, potentially saving women from unnecessary operations and biopsies.
A new study published in The Journal of Nuclear Medicine shows that PET/CT scans with the imaging agent choline can detect recurring prostate cancer sooner than conventional imaging technologies. Researchers found a strong association between PET/CT detection and PSA levels, and suggest using specific criteria to reduce unnecessary scans.
A new study found that positron emission tomography (PET) can accurately depict the extent of neuroblastoma in some patients, especially those with early-stage disease. FDG-PET imaging may also be useful in identifying malignant lesions not readily absorbable by MIBG.
Researchers used PET scans to image HER2 protein levels in breast cancer cells before and after treatment. The study showed a significant reduction in HER2 expression, indicating the treatment's effectiveness.
Researchers have developed a novel form of treatment using an alpha-particle emitting radiopeptide that targets and destroys cancer cells while sparing healthy tissue. The study found that this therapy was significantly more effective at tripling the survival rate of mice with recurrent prostate cancer compared to traditional treatments.
Researchers successfully treated basal cell carcinoma with a non-toxic radioactive patch, showing minimal scarring and no toxicity. The treatment delivered beta radiation to the cancer site, effectively eradicating the malignant cells.
Researchers at SNM's Annual Meeting discovered that combining motion-frozen technology and high-definition PET enhances cardiac imaging, revealing defects invisible to physicians. The method provides exceptional image quality and significantly changes the diagnosis of patients with heart disease.
Researchers have developed a new fully integrated PET/MRI system that can provide whole-body images of rats and small animals. The system offers significant improvements in imaging capabilities, enabling increased understanding of disease characteristics and physiological processes.
A new study presents PET scan results that can accurately diagnose specific types of dementia, such as Alzheimer's disease, in the early stages. This can lead to targeted treatments and improved care outcomes for over 5 million newly diagnosed patients each year.
Researchers at SNM's 56th Annual Meeting propose a novel approach to reconstructing data that could enable the development of a hybrid PET-MR system. The new method uses MR images as a geometrical reference to estimate attenuation and improve accuracy.
Researchers found that combining high-resolution and high-sensitivity collimation in SPECT scans improves image quality for small tumors. This study suggests a new approach to overcome tradeoffs in SPECT image quality, especially for imaging small tumors.
Researchers at SNM's 56th Annual Meeting present a prototype breast imaging system combining positron emission tomography (PET) and magnetic resonance imaging (MRI) technologies. The system aims to provide highly sensitive and specific breast cancer examinations while compensating for the shortcomings of individual PET or MRI systems.
Researchers at the SNM's 56th Annual Meeting found that PET scans can accurately diagnose infections in prosthetic knee joints, outperforming traditional methods. This breakthrough could lead to improved treatment outcomes for patients undergoing joint replacements.
Michael R. Kilbourn, a professor at the University of Michigan, received the prestigious Paul C. Aebersold Award for his contributions to molecular imaging and nuclear medicine. He has advanced research efforts in various areas, including positron emission tomography (PET) radiopharmaceuticals.
Alan Davison, Alun G. Jones, and Michael J. Abrams discovered a new class of technetium complexes that showed localization in cardiac tissue after intravenous administration, leading to the development of myocardial perfusion imaging agents. Their work has enabled millions of people to receive better diagnosis and treatment for heart c...
The Society of Nuclear Medicine and Molecular Imaging has published a comprehensive guide to PET scanning in cancer therapy, providing international guidelines and criteria for response assessment. The new supplement aims to improve tumor response assessment and treatment monitoring with FDG PET imaging.
A study published in the Journal of Nuclear Medicine found that myocardial perfusion testing with gated single photon emission computed tomography (gated SPECT) is a more accurate predictor of prognosis in chronic ischemic heart disease. Gated SPECT identified individuals at risk for future cardiac events, enabling early initiation of ...
A new study found that PET/CT can identify precise location and extent of metastasis, offering a better prognosis for patients with inflammatory breast cancer. The imaging modality provides information on both primary disease site and disease involvement throughout the body.
Researchers developed a hybrid SPECT-CT camera to accurately distinguish cancerous cells from healthy tissue in regional lymph nodes. This technology enables earlier detection and individualized treatment of thyroid cancer.
A nationwide study has confirmed the effectiveness of positron emission tomography (PET) in monitoring tumor activity and changing treatment plans for more than one out of three cancer patients. PET was found to be clinically significant, resulting in a change in treatment in 36% of cases.
Researchers used SPECT to detect brain perfusion abnormalities in fibromyalgia patients, revealing correlations with pain intensity and emotional responses. The study confirms fibromyalgia as a real disorder, not just depression-related, and may improve treatment prediction.
The SNM Technologist Section (SNMTS) has partnered with IBA Molecular and Philips to provide a leadership training program for young professionals in nuclear medicine technology. The program aims to develop the leadership skills necessary to excel in the field.
A single dose of EPO immediately after a heart attack reduces apoptosis and limits damage to the heart. The study found a 2.7-fold reduction in tracer accumulation, indicating less damage to heart tissue.
The Journal of Nuclear Medicine is now free and open to the public six months after publication, accelerating access to new research and advancing understanding of nuclear medicine and molecular imaging. This move reflects the journal's exceptional quality and influence as an academic and professional resource.
A recent study found that positron emission tomography (PET) scans led to changes in treatment plans for more than half of patients with suspected recurrent colorectal cancer. The study, conducted at four sites in Australia, involved 191 patients and showed that PET scans identified additional disease sites in 48% of patients, allowing...
A new PET study reveals a direct correlation between hereditary personality traits, particularly reward dependency, and brain chemistry. Individuals with high reward dependence have higher opiate receptor binding in the ventral striatum, associated with increased cravings and addictive behavior.
Thakur's work has advanced excellence in healthcare through the development of radiopharmaceuticals and imaging techniques, including a new monoclonal antibody for detecting infection. The 2008 Benedict Cassen Prize recognizes his major advance in basic or clinical nuclear medicine science.
Peter J. Ell, director of the institute of nuclear medicine and chair of nuclear medicine at UCL, is awarded the Georg Charles de Hevesy Nuclear Pioneer Award for laying the foundations of nuclear medicine in Europe. The award recognizes his pioneering efforts in developing molecular imaging techniques, including SPECT.
The Society of Nuclear Medicine and Molecular Imaging (SNM) has awarded $170,000 in research grants to support nuclear medicine and molecular imaging research. This funding supports independent research projects, including the work of talented young scientists who will further advance diagnostic tools and treatments.
The Society of Nuclear Medicine and Molecular Imaging (SNM) has awarded significant grants to support molecular imaging research, providing opportunities for young scientists to pursue cutting-edge research in emerging fields. The awards aim to advance patient care by investing in promising researchers working on vital medical practices.
Researchers developed a promising new technique to track genetically engineered cells using antibody fragments as reporter genes, which could advance disease treatment. The technique offers several advantages over existing methods, including improved specificity and accuracy.
Researchers used PET imaging to detect structural and functional alterations in the circulatory system of asymptomatic diabetic patients. The study found that PET revealed coronary vascular dysfunction as a precursor to coronary artery disease, which may precede structural changes in the arterial wall.
Researchers used PET imaging to assess the effects of methylphenidate on brain function in healthy adults. The study found that MP improved performance in those who needed it, but deteriorated it in others.
Researchers developed a method to track mesenchymal stem cells in tumors using noninvasive molecular imaging technology. The technique offers promise for personalized medicine and gene-modified stem cell therapies to fight cancer.
Researchers found that hormone replacement therapy maintained coronary endothelial function, while those without HRT experienced worsening endothelium function. Postmenopausal women who gave up HRT demonstrated the most severe drop in endothelial function.
Researchers developed a therapeutic system targeting HIF-1 activated cancer cells, showing success in laboratory tests. The system uses a reporter gene to detect and treat hypoxic cancer cells that are resistant to traditional treatments.
A new study presents radioimmunotherapy targeting viral antigens as a novel option to treat or prevent many viral cancers. The therapy offers 'exquisite specificity' in targeting cancer cells expressing viral antigens, allowing for more precise diagnosis and treatment.
A new nuclear medicine imaging test, scintigraphy, has been shown to be highly effective in detecting gastroesophageal reflux disease (GERD) in children with respiratory problems. The test detected GERD in 66.6% of children with asthma or lower respiratory tract infections, outperforming traditional barium X-ray technology.
Researchers used molecular imaging to monitor Alzheimer's disease progression, identifying those at risk and assessing therapy effectiveness. The study found that beta-amyloid imaging can detect AD earlier and distinguish it from other dementias.
The first semiconductor-based PET scanner demonstrates improved spatial resolution and reduced noise, enabling better characterization of diseases such as partial epilepsy and nasopharyngeal cancer. This technology holds promise for advancing early-stage diagnoses and assessing patient responses to therapies.
Two images, one showing neuroendocrine cancer relapse and the other a foot infection, demonstrate molecular imaging's ability to provide precise snapshots of disease anatomy. Imaging techniques are increasingly being used in combination to improve treatment planning and patient outcomes.
Scientists used Exploratory Investigational New Drug (ExpIND) to evaluate four 18F-labeled imaging agents in patients with Alzheimer's disease, identifying the best detector of amyloid plaque deposits. The study suggested that ExpIND could speed up the development of new radiopharmaceuticals while ensuring patient safety.
The new scanner enables physicians to determine stages of breast cancer in patients already diagnosed, rather than as a mammography screening tool. It also helps plan breast cancer surgeries and detect early whether drug treatments are effective.